The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ALXO FINANCIAL STATEMENTS

Alx Oncology Holdings  — balance sheet, income statement and cash flow trends

ALXOAlx Oncology Holdings 

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-150 M-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-150 K $ · -Infinity%Operating Income-82.8 M $ · -Infinity%Pre-tax Income-80.9 M $ · -Infinity%Net Income to Owners-80.9 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-150 K $—
Operating Income-82.8 M $—
EBITDA-79.4 M $—
Net Income to Owners-80.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets160.8 M
  • Equity136.2 M $85%
  • Current Liabilities14.8 M $9%
  • Long-term Liabilities9.9 M $6%

Key Figures

YoY change
Total Assets160.8 M $+68.7%
Total Liabilities24.6 M $-20.3%
Total Equity136.2 M $+111.4%
Cash & ST Investments138.2 M $+74.3%
Total Debt9.7 M $-40.0%
Net Debt-13 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-89.4 M $Operating-170.9 M $Investing279.8 M $Financing19.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-89.4 M $—
Capital Expenditures222 K $-29.7%
Free Cash Flow-89.6 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ALXO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.